Xenetic Biosciences Inc (XBIO) financials · rev $3.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Xenetic Biosciences Inc (XBIO) rev $3.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $2.98M | $2.50M |
| Operating Income | -$2.83M | -$4.20M |
| Net Income | -$2.68M | -$3.96M |
| EPS (Diluted) | -$1.58 | -$2.57 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $8.36M | $6.90M |
| Current Assets | $8.05M | $6.59M |
| Cash & Equivalents | $7.88M | $6.17M |
| Total Liabilities | $968.0K | $894.3K |
| Current Liabilities | $968.0K | $894.3K |
| Shareholders' Equity | $7.40M | $6.01M |
| Retained Earnings | -$199.9M | -$197.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$2.29M | -$2.82M |
| Financing Cash Flow | $4.00M | N/A |
FAQ
What is XBIO P/E and revenue?
Xenetic Biosciences Inc (XBIO) rev $3.0M.
What is XBIO revenue?
Xenetic Biosciences Inc last cached revenue is $2.98M (FY2025).
Is XBIO profitable?
Xenetic Biosciences Inc last cached net income is -$2.68M (FY2025).
What are XBIO total assets?
Xenetic Biosciences Inc last cached total assets are $8.36M (FY2025).
What is XBIO free cash flow?
No cached cash-flow row for XBIO yet.
Not investment advice. Cached statements, not a live tape.